Weekly Movers
August 27th, 2024
Marinus Pharmaceuticals, Inc. is making substantial advancements in the biopharmaceutical sector, concentrating on innovative treatments for neurological disorders.
This overview will provide you with a comprehensive understanding of the company’s...
Read More
August 26th, 2024
Genprex Inc. is at the forefront of gene therapy innovation, with the objective of transforming the landscape of cancer treatment and addressing other serious diseases.
With a mission focused on advancing healthcare through groundbreaking...
Read More
August 26th, 2024
Autolus Therapeutics stands at the forefront of innovative CAR-T cell therapies, revolutionizing cancer treatment through cutting-edge technology.
This overview provides insights into the company’s mission, highlights significant advancements in...
Read More
August 26th, 2024
Immix Biopharma is making significant strides in the oncology landscape, particularly with its innovative CAR-T therapy.
As the company advances through critical clinical trials, it is essential for investors and healthcare professionals to...
Read More